Taiwan's Adimmune To Sue Critics Of Company's H1N1 Vaccine
This article was originally published in PharmAsia News
Executive Summary
Taiwan drug maker Adimmune filed a defamation suit against the people accused of raising doubts about the safety of the company's H1N1 flu vaccine